Biology and Therapeutic Advances for Pediatric Osteosarcoma

Biology and Therapeutic Advances for Pediatric Osteosarcoma Neyssa Marina, Mark Gebhardt, Lisa Teot, Richard Gorlick Oncologist 2004; 9: 422-441 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in pediatric oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Discuss etiologic and biologic factors in osteosarcoma. Select the appropriate diagnostic work-up for patients with newly diagnosed osteosarcoma. Select appropriate multidisciplinary treatment for patients with newly diagnosed osteosarcoma. Discuss various surgical approaches to the management of newly diagnosed osteosarcoma. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: July 21, 2004 Most Recent Review: July 21, 2004* Most Recent Update: July 21, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.